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Objective. Herpesvirus infection can cause immunosuppression and then act as a modifier of apical periodontitis,
influencing the disease severity and response to treatment. The purpose of this study was to investigate if herpesvirus
infection, as inferred by salivary carriage, may influence the endodontic treatment outcome.
Study design. The study population included 72 patients who had root canals treated more than 1 year previously
because of necrotic pulps and apical periodontitis. At the follow-up examination, 27 of these patients presented with
posttreatment apical periodontitis (failure) and 45 individuals exhibited healed/healing periradicular tissues (success).
Saliva was collected from these individuals, DNA was extracted, subjected to multiple displacement amplification, and
screened by polymerase chain reaction (PCR) assays for the presence of 6 herpesviruses: herpes simplex virus types 1
and 2 (HSV-1/2), Epstein-Barr virus (EBV), human cytomegalovirus (HCMV), human herpesvirus-6 (HHV-6), and
human herpesvirus-8 (HHV-8).
Results. Except for HSV-1/2, all other herpesviruses were detected in saliva from both healed/healing and diseased
groups. HHV-8 was the most frequent herpesvirus found in saliva (84% in success, 89% in failure), followed by
HCMV (22% in success, 30% in failure), EBV (16% in success, 18.5% in failure) and HHV-6 (7% in success, 15% in
failure). No significant association of herpesvirus carriage in saliva with poor treatment outcome was discernible in the
population studied (P  .05).
Conclusions. Data from the present study suggest that herpesvirus infection may not influence the outcome of
endodontic treatment. Further longitudinal studies are warranted to confirm these findings. (Oral Surg Oral Med Oral
Pathol Oral Radiol Endod 2011;112:678-683)Apical periodontitis is primarily caused by bacteria, but
other conditions may conceivably influence its progres-
sion, form, severity, and response to treatment.1 These
conditions are usually referred to as disease modifiers.
The activity of disease modifiers, as for instance alter-
ing the host defense to infection, might help explain
why some asymptomatic teeth become symptomatic
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678overnight, why some lesions take too long to heal after
endodontic treatment, and why some apparently well-
treated root canals still result in failure.1,2 There is
some evidence showing that diabetes may function as a
modifier of apical periodontitis.3,4 Other potential dis-
ease modifiers of endodontic interest include polymor-
phisms in genes related to the immune response5 and
smoking.6
The past years have witnessed an increasing interest
in the potential role of herpesviruses in the pathogen-
esis of apical periodontitis. Members of this group of
viruses have been detected in symptomatic apical peri-
odontitis lesions,7 endodontic abscesses,8,9 large le-
sions,10 and lesions from human immunodeficiency
virus (HIV)-positive patients.11 It has been hypothe-
sized that herpesviruses may be implicated in the patho-
genesis of apical periodontitis as a direct result of virus
infection or as a result of virally induced impairment of
local host defenses, which might give rise to over-
growth of pathogenic bacteria in the very apical part of
the root canal.12 Therefore, considering that herpesvi-
rus infection can cause focal immunosuppression, it is
possible to surmise that it may act as a disease modifier
and influence apical periodontitis progression, severity,
and response to treatment.
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eral adult population may reach values as high as
90%.13 Herpesviruses represent the most prevalent
group of viruses found in human saliva, and their
occurrence is usually caused by shedding of virions
from infected oral sites, including salivary glands,
oral mucosa, or gingival sulcus.14,15 Interestingly,
even systemically healthy adults may continually and
asymptomatically shed detectable herpesvirus DNA
in saliva.13
The hypothesis for the present study is that herpes-
virus infection may negatively affect the response of
apical periodontitis to endodontic treatment. The ratio-
nale is that herpesvirus-infected defense cells are at-
tracted to the periradicular tissues in response to bac-
terial infection and, once there, the viruses become
activated and induce local immunosuppression. This
would favor pathogenicity of bacteria persisting at the
apical canal and therefore impair periradicular healing.
To evaluate this hypothesis, periradicular sampling
would be the best approach for detection of herpesvirus
infection, but it would be ethically impossible to collect
these samples from healed or healing cases. Thus, sa-
liva may be the best sampling material to survey for the
presence of herpesvirus infection. If the hypothesis of
this study is confirmed, herpesvirus detection in saliva
at the time of treatment might be further investigated
for its possible role as predictor of poor prognosis.
Highly sensitive and specific molecular microbiology
methods have greatly facilitated the detection of virus
in clinical material.16 Hence, these methods hold the
potential of using herpesvirus salivary detection to in-
dicate a risk for poor endodontic treatment outcome.
The present study was undertaken to search for an
association between herpesvirus infection (as inferred
by their presence in saliva) and the endodontic treat-
ment outcome. For this, patients subjected to follow-up
examination for analysis of the outcome of the end-
odontic treatment had their saliva collected and
screened for the presence of 6 human herpesviruses.
MATERIAL AND METHODS
Individuals and inclusion criteria
The population sample that met the inclusion criteria,
described later in this article, involved 72 adult indi-
viduals (41 females and 31 males). A questionnaire was
given to all individuals participating in the study so as
to obtain information regarding their general health and
habits. The systemic conditions and acquired habits of
interest for this study, as they might act as disease
modifiers and then as covariates, included diabetes (7
individuals), hypertension (14 individuals), HIV infec-
tion (none reported), and smoking (9 individuals). Theprotocol for this study was approved by the Ethics
Committee of the Estácio de Sá University.
Treatment outcome was determined on the basis of
radiographic and clinical evaluations. Immediate post-
operative radiographs at the time of treatment available
in the Dental School records and follow-up radiographs
of treated teeth were taken using film holders and
treatment outcome was categorized as follows:
1. Healed: Contour and width of the periodontal liga-
ment space (PDL) were normal or PDL contour was
widened mainly around excess filling. Appearance
of the surrounding bone was normal. These cases
were categorized as success (controls).
2. Healing: Periradicular radiolucency was clearly de-
creasing in size. For the purpose of this study, these
teeth were also categorized as success (controls),
because a significant level of healing was observed.
Cases with uncertain healing were excluded.
3. Diseased (not healed): Periradicular radiolucency
was unchanged or increased in size. These cases
were categorized as failure.
In teeth with more than one root, the least-favorable
outcome was registered. Two experienced endodontists
independently analyzed the radiographs under magni-
fication and in the only 4 cases where disagreement
occurred, a third observer was consulted. Clinical ex-
amination was also performed to check for other signs/
symptoms of treatment failure, including pain, swell-
ing, and sinus tracts.
Rigid inclusion criteria were used to select patients.
To be enrolled, each individual had to exhibit only 1
root canal–treated tooth or more than 1 treated tooth
exhibiting the very same periradicular status at the
follow-up examination (i.e., healthy/healing or dis-
eased). All individuals presented with pulp necrosis and
apical periodontitis at the time of treatment, which in
turn should have been completed for at least 1 year
previously. Treated teeth had both adequate root canal
fillings and adequate coronal restorations. Root canal
treatment was ranked as adequate based on the follow-
ing aspects: all canals were obturated, no voids in the
filling mass were present, and the apical terminus of the
filling was 0 to 2 mm short of the radiographic apex.
Coronal restoration was ranked as adequate when it was
a permanent restoration that appeared clinically and
radiographically intact, with no detectable signs of
overhangs, open margins, or recurrent caries. All end-
odontic treatments were conducted by either graduate
students or specialists.
Following these inclusion criteria, the diseased
group (failure) was composed of 27 patients and the
healed/healing group (success) was composed of 45
individuals.
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Saliva samples were taken from the individuals at the
time of follow-up examination. Sampling and DNA
extraction procedures were performed as described pre-
viously.5,17 Samples from 48 patients were available
from a previous study and stored frozen.5 Fresh
samples were taken from another 24 patients who
had not participated in that previous study. To im-
prove the performance of polymerase chain reaction
(PCR) assays for virus detection, DNA extracts from
saliva were subjected to multiple displacement am-
plification (MDA) by using the Illustra GenomiPhi
V2 DNA amplification kit (GE Healthcare, Piscat-
away, NJ) following the manufacturer’s instructions.
PCR assays
Initially, to ascertain the availability of human DNA
for analysis, aliquots of 2 L of the MDA products
from salivary DNA were subjected to PCR using prim-
ers directed to the T-cell receptor V22 gene.18 These
results were confirmed by using PCR directed to the
human -globin gene.19
The human viruses targeted in this study were the
following: herpes simplex virus types 1 and 2 (HSV-
1/2), Epstein-Barr virus (EBV), human cytomegalovi-
rus (HCMV), human herpesvirus-6 (HHV-6), and hu-
man herpesvirus-8 (HHV-8). A multiplex nested PCR
approach was used to simultaneously detect HSV-1/2,
HCMV, and EBV.20 Nested PCR assays were used for
detection of EBV,8 HCMV,8 HHV-6,21 and HHV-8.22
Aliquots of 2 L of MDA products were used as
templates in each individual PCR reaction for virus
detection. All PCR reactions and cycling parameters for
virus detection are summarized in a previous study,9
except for the nested PCR assays targeting HCMV and
EBV, which followed the protocols by Chen et al.8
All PCR analyses were performed in duplicate. Pos-
itive and negative controls were included in all batches
of samples analyzed. Positive controls for viruses con-
sisted of DNA extracted from clinical samples (blood
or saliva) previously tested positive for each target
virus as determined by PCR and sequencing. One neg-
ative control consisting of sterile ultrapure water in-
stead of sample was included for every 5 samples in all
batches of samples analyzed.
Amplicons were separated by electrophoresis in
1.5% agarose gel, stained with ethidium bromide, and
viewed under ultraviolet transillumination. A 100–base
pair DNA ladder digest (New England Biolabs, Bev-
erly, MA) served as the molecular size standard. Rep-
resentative products from positive PCR reactions were
sequenced to confirm identification.Statistical analysis
The data concerning the presence of the different
herpesviruses in saliva of individuals with healed/heal-
ing or diseased teeth were statistically analyzed by
means of the Pearson 2 test or the Fisher 2-tailed exact
test. The latter was used whenever at least one cell of
the 2  2 contingency table had a value less than 5.
Several other factors (systemic conditions, smoking,
race, and gender) were also evaluated for associations
with treatment outcome to check if they could act as
covariates. The Student t test was used for analyses of
the age distribution between the 2 groups. Significance
level was always set at P less than .05. Prevalence of
the different herpesviruses in saliva from subpopula-
tions according to systemic conditions, smoking, and
gender were also recorded, but statistical tests were not
performed for these subdivided data because of the
resulting too low sample size.
RESULTS
The characteristics of the study individuals and their
relationship with the periradicular status are depicted in
Table I. Overall analysis showed that no systemic con-
dition or acquired habit was significantly associated
with posttreatment disease (P  .05). Gender and race
had no significant influence on treatment outcome ei-
ther (P  .05). Therefore, none of the conditions were
found to serve as covariates.
Table II displays the results of the prevalence of the
different herpesviruses in saliva of patients with or
without radiographic evidence of posttreatment apical
periodontitis. Except for HSV-1/2, all other herpesvi-
ruses were detected in saliva from both healed/healing
and diseased groups. Overall, HHV-8 was the most
frequent herpesvirus found in saliva (62/72 individuals,
86%), followed by HCMV (18/72, 25%), EBV (12/72,
17%), and HHV-6 (7/72, 10%). Only 4 patients (all of
them healed/healing cases) showed none of the target
viruses. No significant associations were detected be-
tween any of the target viruses and treatment outcome
(P  .05).
DISCUSSION
One of the models proposed for the role of herpes-
virus infection in the pathogenesis of apical periodon-
titis claims that the virus causes localized immunosup-
pression, which consequently favors overgrowth of
bacteria in the apical root canal.12 Localized inflamma-
tion in the periradicular tissues caused by intraradicular
bacterial infection results in attraction of host defense
cells infected by herpesviruses. As these cells infiltrate
and accumulate in the inflamed tissues, the herpesvi-
ruses can be reactivated spontaneously, by concomitant
bacterial infection or during periods of reduced host
OOOOE
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herpesvirus infection might function as a modifier of
apical periodontitis and play a role in altering the dis-
ease response to treatment. Although studies have
clearly demonstrated a strong association of bacteria
located in the apical canal with posttreatment apical
periodontitis,23,24 it is also known that sterilization of
the root canal system is not attainable with current
techniques, instruments, and materials. Therefore, bac-
teria are expected to remain in the great majority
of treated canals, and successful treatment is expected
Table I. Characteristics of study subjects and associa-





Characteristics n (%) n (%) P value
Gender
Female 28 (67.5) 13 (32.5) .24*
Male 17 (56) 14 (44)
Female  EBV 4 (50) 4 (50)
Male  EBV 3 (75) 1 (25)
Female  HCMV 7 (54) 6 (46)
Male  HCMV 3 (60) 2 (40)
Female  HHV-6 3 (60) 2 (40)
Male  HHV-6 0 (0) 2 (100)
Female  HHV-8 21 (68) 10 (32)
Male  HHV-8 17 (55) 14 (45)
Race
White 38 (67) 19 (33) .15*
African-Brazilian 7 (47) 8 (53)
Systemic condition
Diabetic 3 (43) 4 (57) .41†
Nondiabetic 42 (65) 23 (35)
Diabetic  EBV 2 (100) 0 (0)
Diabetic  HCMV 1 (33) 2 (67)
Diabetic  HHV-6 0 (0) 0 (0)
Diabetic  HHV-8 3 (50) 3 (50)
Hypertensive 11 (79) 3 (21) .22†
Nonhypertensive 34 (59) 24 (41)
Hypertensive  EBV 3 (100) 0 (0)
Hypertensive  HCMV 1 (50) 1 (50)
Hypertensive  HHV-6 0 (0) 0 (0)
Hypertensive  HHV-8 10 (83) 2 (17)
Habits
Smoker 3 (33) 6 (67) 0.07†
Nonsmoker 42 (67) 21 (33)
Smoker  EBV 1 (33) 2 (67)
Smoker  HCMV 0 (0) 1 (100)
Smoker  HHV-6 0 (0) 1 (100)
Smoker  HHV-8 3 (37.5) 5 (62.5)
Age, y 42.5 (18.1)‡ 46.6 (15.1)‡ 0.33§
EBV, Epstein-Barr virus; HCMV, human cytomegalovirus; HHV-6,




‡Mean ( standard deviation).when maximum bacterial reduction is achieved and theremaining bacteria are in levels that are compatible
with tissue healing.25 However, the possibility exists
that the host response can be influenced by disease
modifiers and, as a consequence, cases with low num-
bers of residual bacteria might not heal or might take
longer to remit in patients with some unfavorable dis-
ease modifier, in spite of adequate root canal treatment.
Although herpesvirus infection might be included in
this category of disease modifier influencing the re-
sponse of apical periodontitis to treatment, this was not
observed in the present study for any of the target
herpesviruses. Whereas HSV-1/2 was not found in any
of the samples, all of the other 4 herpesviruses were
detected in saliva from both success and failure groups.
Prevalences for these 4 viruses were slightly higher in
failure cases, but not enough to reach statistical signif-
icance. Therefore, no association of herpesvirus car-
riage in saliva with poor treatment outcome was dis-
cernible in the population studied.
One important limitation of this study is that al-
though the evaluation of treatment outcome was retro-
spective, analysis of virus presence was cross sectional,
as this information was available only at the time of
recall. Because saliva samples were taken at the time of
follow-up examination, it is not possible to infer when
infected individuals acquired the virus. Also, the virus
presence in saliva may have been only transient after a
recent transfer from another infected individual, which
would then represent a carriage state with no infection.
For the hypothesis of this study to be confirmed and
virus infection be considered a predictor of poor out-
come or delayed healing response, the individual
should have been infected before the endodontic treat-
ment or shortly thereafter. However, this study was just
a preliminary cross-sectional analysis searching for as-
sociation. Longitudinal studies are required to confirm
Table II. Prevalence of different herpesviruses in sa-





Target virus n 	 45 n 	 27 P value
HHV-8 38 (84%) 24 (89%) .73*
HCMV 10 (22%) 8 (30%) .48†
EBV 7 (16%) 5 (18.5%) .74†
HHV-6 3 (7%) 4 (15%) .41*
HSV-1/2 0 (0%) 0 (0%) —
EBV, Epstein-Barr virus; HCMV, human cytomegalovirus; HHV-6,
human herpesvirus-6; HHV-8, human herpesvirus-8; HSV-1/2, herpes
simplex virus types 1 and 2.
*Fisher exact test.
†Pearson 2.or refute the present findings.
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First, although failure cases might have been treated by
surgery and virus detection ascertained directly using
the lesion as a source of DNA, this would not be
possible and ethically viable for healed/healing cases.
Second, had any association with poor outcome been
disclosed for the test viruses, development of a test to
predict the treatment outcome would be easier because
saliva is promptly available and no invasive technique
is required for sampling.
In general, the most prevalent herpesvirus was
HHV-8 (86%), followed by HCMV (25%), EBV
(17%), and HHV-6B (10%). The prevalence values for
most viruses (except for HHV-8) were relatively lower
when compared with many other studies.26-28 HHV-8
was prevalent in saliva, and this result is in disagree-
ment with some studies in healthy general adult popu-
lations from the United States and northern Europe.29,30
However, HHV-8 has been found to be more prevalent
in individuals from other geographic locations, includ-
ing Brazilian Amerindians, Africans, and adult popula-
tions from southern European and Middle Eastern Med-
iterranean regions.31-33 Our previous investigation of
endodontic abscesses in Brazilian patients also demon-
strated a high prevalence of HHV-8.9 This suggests a
geographic influence on the occurrence of HHV-8. In
fact, all these discrepancies in prevalence, for more or
less depending on the target herpesvirus, may be a
reflection of the geographic differences among the pop-
ulations studied, different oral conditions of the sam-
pled population, and the different methods used for
sample taking/processing and virus identification.
Other potential disease modifiers, such as diabetes,
hypertension, and smoking, were also tested for their
association with treatment outcome so as not to act as
confounding variables. None of them was significantly
associated with endodontic treatment outcome. As for
diabetes, the present findings are in disagreement with
the literature.3,4 Hypertension as well has not been
shown to be a factor influencing apical periodontitis,34
whereas data related to smoking are still conflict-
ing.5,6,35 However, these analyses were not the main
scope of this study and are substantially underpowered,
as the very low numbers of individuals with diabetes
(n 	 7), hypertension (n 	 14), or smoking habit (n 	
9) do not allow for a robust statistical analysis to be
performed.
In conclusion, the current study of a relatively small
sample size demonstrated that herpesvirus infection as
inferred from salivary carriage was not associated with
poor outcome of endodontic treatment in Brazilians.
Further longitudinal studies involving a larger sample
size and from different geographic populations are
needed to help clarify this issue.REFERENCES
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